Susquehanna Fundamental Investments’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-273,412
Closed -$675K 978
2025
Q1
$675K Buy
273,412
+35,947
+15% +$85.5K 0.01% 775
2024
Q4
$746K Buy
+237,465
New +$1.15M 0.01% 783
2024
Q2
$706K Buy
+160,167
New +$751K 0.02% 619

Other funds holding SLRN

Susquehanna Fundamental Investments's SLRN Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 273,412 shares — an estimated $675K sold.

Susquehanna Fundamental Investments first reported a position in SLRN in Q2 2024 and held it in 3 quarters. The position peaked at $746K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 273,412 ACELYRIN shares in Q2 2025, an estimated $675K.
  • Susquehanna Fundamental Investments first reported a position in ACELYRIN in Q2 2024 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's ACELYRIN position peaked at $746K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.